Bruno Coelho Cavalcanti
Overview
Explore the profile of Bruno Coelho Cavalcanti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nascimento J, Silva Abreu F, Holanda T, Oliveira Dos Santos Fontenelle R, Prado J, Marinho E, et al.
Pharmaceuticals (Basel)
. 2024 Nov;
17(11).
PMID: 39598354
Nanoemulsions (NEs) possess properties that enhance the solubility, bioavailability and therapeutic efficacy of drugs. Chalcones are compounds known for their antifungal properties. In this study, we evaluated different emulsification techniques...
2.
da Silva L, Rodrigues D, de Farias Cabral V, da Silva C, Sa L, de Andrade-Neto J, et al.
Braz J Microbiol
. 2024 Sep;
55(4):3721-3731.
PMID: 39297913
Objectives: This study addressed the need for new treatments for severe Candida infections, especially resistant strains. It evaluated the antifungal potential of geraniol alone and with fluconazole against various Candida...
3.
Queiroz H, da Silva L, Barroso F, Sa L, de Andrade Neto J, Costa E, et al.
Future Microbiol
. 2024 Sep;
19(16):1365-1375.
PMID: 39235062
To evaluate the antifungal activity of amlodipine against strains of spp. and to its possible mechanism of action. Broth microdilution tests were used to determine the minimum inhibitory concentration, while...
4.
de Farias Cabral V, Rodrigues D, Sa L, Moreira L, da Silva C, de Andrade Neto J, et al.
Braz J Microbiol
. 2024 Aug;
55(4):3617-3628.
PMID: 39198376
Candida species are among the priority pathogens in the area of research and development. Due to the problems associated with resistance to antifungals, new therapeutic alternatives are necessary. In this...
5.
Moreira L, de Farias Cabral V, Rodrigues D, Barbosa A, Silveira M, Coutinho T, et al.
Braz J Microbiol
. 2024 Aug;
55(4):3679-3690.
PMID: 39179891
The increase in fungal resistance is a major public health concern. In this context, Candida spp. is an important genus related to invasive diseases, especially in immunosuppressed patients. The relevance...
6.
Cavalcanti B, Magalhaes I, Rodrigues D, de Farias Cabral V, Barbosa A, Sa L, et al.
Future Microbiol
. 2024 Aug;
19(15):1309-1320.
PMID: 39101446
Evaluate the anticandidal effect of Kunth essential oil and its interaction with azoles and N-acetylcysteine (NAC) against planktonic cells and biofilms. Broth microdilution and checkerboard methods were used to evaluate...
7.
Ferreira T, Leitao A, da Silva L, Sa L, de Farias Cabral V, Rodrigues D, et al.
Future Microbiol
. 2024 Jul;
19(13):1157-1170.
PMID: 39012219
To evaluate the antifungal activity of mangiferin against spp. resistant to fluconazole. The antifungal activity of mangiferin was assessed using broth microdilution and its interaction with azoles and amphotericin B...
8.
Barbosa A, Leitao A, de Oliveira L, Rodrigues D, de Farias Cabral V, Moreira L, et al.
J Med Microbiol
. 2024 Jul;
73(7).
PMID: 38979984
The development of new antifungal drugs has become a global priority, given the increasing cases of fungal diseases together with the rising resistance to available antifungal drugs. In this scenario,...
9.
Barroso F, da Silva L, Queiroz H, Sa L, da Silva A, da Silva C, et al.
Future Microbiol
. 2024 Jun;
19(8):667-679.
PMID: 38864708
The present study investigated the antimicrobial effectiveness of a rhamnolipid complexed with arginine (RLMIX_Arg) against planktonic cells and biofilms of methicillin-resistant (MRSA). Susceptibility testing was performed using the Clinical &...
10.
Nogueira F, de Souza A, Araujo N, de Souza L, Silva R, de Oliveira Bezerra de Sousa D, et al.
Braz J Microbiol
. 2024 Apr;
55(2):1205-1217.
PMID: 38594492
The incidence of Candida species resistant to traditional antifungal drugs is increasing globally. This issue significantly impacts patients' lives and increases healthcare expenses, confirming the need to develop novel therapeutic...